Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells-Reference-Cited by-同舟云学术

Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells

Published:2013-09-16 Issue:8 Volume:191 Page:4165-4173
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Terp Mikkel G.,Olesen Kristina A.,Arnspang Eva C.,Lund Rikke R.,Lagerholm B. Christoffer,Ditzel Henrik J.,Leth-Larsen Rikke

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference23 articles.

1. Microenvironmental regulation of metastasis

2. Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry

3. Efficient Isolation and Quantitative Proteomic Analysis of Cancer Cell Plasma Membrane Proteins for Identification of Metastasis-Associated Cell Surface Markers

4. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73).

5. Extracellular adenosine triphosphate and adenosine in cancer

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of CD73 in predicting the response to immunotherapy in head and neck cancer patients;Pathology - Research and Practice;2024-08

2. Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors;Seminars in Immunopathology;2024-07-25

3. CD73 Is an Immunometabolic Biomarker of Poor Prognosis in Patients With Primary Cutaneous Squamous Cell Carcinoma and Hematologic Malignancy;Dermatologic Surgery;2024-07-08

4. GRHL2 suppression of NT5E/CD73 in breast cancer cells modulates CD73-mediated adenosine production and T cell recruitment;iScience;2024-05

5. Purinergic pathways and their clinical use in the treatment of acute myeloid leukemia;Purinergic Signalling;2024-03-06